NP-CSIC002
N/A
Report date: 2023/01/19 16:46:50
NME
Base Information
Drug NameNP-CSIC002
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeurizon Pharma GBR
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A